Aptose Biosciences (APTO) has released an update to notify the public and investors about a regulation fd disclosure.
On January 31, 2024, the Registrant released a press statement. The content of this press release is not considered officially “filed” under the Securities Exchange Act of 1934 and is not automatically included in any filings with the Securities Act of 1933 or the Exchange Act, unless explicitly stated in the filings.
For further insights into APTO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
